Neuroscience Antibodies and Assays Market Share

Statistics for the 2023 & 2024 Neuroscience Antibodies and Assays market share, created by Mordor Intelligence™ Industry Reports. Neuroscience Antibodies and Assays share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Neuroscience Antibodies and Assays Industry

The neuroscience antibodies and assays market is moderately competitive and consists of several major players. In terms of market share, few major players are currently dominating the market. 

Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck KGaA, F. Hoffmann-La Roche, Cell Signaling Technology, Inc, BioLegend, Inc, Abcam Plc, Rockland Immunochemicals, Inc, GenScript and Santa Cruz Biotechnology, Inc.

Neuroscience Antibodies & Assays Market Leaders

  1. Thermo Fisher Scientific

  2. Bio-Rad Laboratories, Inc

  3. F. Hoffmann-La Roche Ltd

  4. Cell Signaling Technology, Inc

  5. Merck KGaA

*Disclaimer: Major Players sorted in no particular order

Neuroscience Antibodies And Assays Market Concentration

Neuroscience Antibodies and Assays Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)